Logo

List of Chronobiotics



Name SMILES FDA Status Effects Targets Mechanisms Articles
CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C#N Approved Arntl (gene) , PER3 Angiotensin receptor binding, PER3
C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C=C32 None CRY1-PER2 complex , CLOCK-BMAL1 , Arntl (gene) Disruption of circadian clock, Interferes with CLOCK–BMAL1, aryl hydrocarbon receptor (AhR) binding
C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C6=CC=CC=C6C5=CC=C4 none mPer2 , mPer1 , CRY1-PER2 complex , CRY1 , CLOCK-BMAL1 , Arntl (gene) Disruption of circadian clock, Core clock suppression, Interferes with CLOCK–BMAL1, Targets BMAL1–CLOCK DNA-binding activity, aryl hydrocarbon receptor (AhR) binding
C1=CC=C2C=C3C=CC=CC3=CC2=C1 none CRY1-PER2 complex , CLOCK-BMAL1 Disruption of circadian clock, Core clock suppression, Interferes with CLOCK–BMAL1, aryl hydrocarbon receptor (AhR) binding
C1=CC=C2C=CC=CC2=C1 none CLOCK-BMAL1 Core clock modulation, Core clock suppression, Bmal1, BMAL1 expression modulation
CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)O)CCC(=O)O.[Fe+2] Not approved CLOCK-BMAL1 Serves as a cofactor in various hemoproteins (e.g., hemoglobin, cytochromes) and can modulate transcription factors (e.g., REV-E
COC1=CC(=CC(=C1)/C=C/C2=CC=C(C=C2)O)OC Not approved mPer2 , mPer1 , CRY1-PER2 complex , CRY1 , CLOCK-BMAL1 , Arntl (gene) , BMAL1 expression (induction) Core clock modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation, BMAL1 expression modulation, Activation of CLOCK/Bmal1 mediated transcription, SIRT1-mediated peroxisome proliferator-activated receptor coactivator 1α (PGC-1α) deacetylation in sleep-restricted mice
CCCCCNC(=O)N1CCC(C1)CN(CC2=CC=C(C=C2)Cl)CC3=CC=C(S3)[N+](=O)[O-] none mPer2 , REV-ERBα , BMAL1 expression (induction) , Per2 expression Agonist REV-ERB alpha
CC(C)(C)OC(=O)CN(CC1=CC=C(C=C1)Cl)CC2=CC=C(S2)[N+](=O)[O-] none REV-ERBα Antagonist of Rev-Erb nuclear receptors
CC(C1=CC(=C(C=C1)OC)OC)C(=O)C2=C(C=C(C=C2)C(C)(C)C#C)OC none CLOCK-BMAL1 Core clock modulation, Bmal1, BMAL1 expression modulation
C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O Approved ROR gamma ROR, RORγ binding
CC1=CC=C(C=C1)N2C(=O)N(C(=O)S2)CC3=CC=C(C=C3)F none ROR gamma ROR, RORγ binding
C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4([C@@H](C[C@@H](C5)O)O)C)C)O[C@]16CCC(=C)CO6 none RORA , RORα , NR1F1 ROR
COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C(=C(C(=C3OC)OC)OC)OC)OC Not approved RORA Core clock modulation, ROR, PER gene exspression modulation, Activation of CLOCK/Bmal1 mediated transcription
C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NCC3=CC=C(C=C3)O Not approved Neuropeptide Y Y1 receptor Neuropeptide Y1 receptor binding
CCC1=CC=C(C=C1)N(CC(C)C)S(=O)(=O)C2=CC(=C(C=C2)OCC3CCOCC3)CO none ROR gamma ROR, RORγ binding
CC(C)NCCN(C(C)C)S(=O)(=O)C1=C(C=C(C=C1)Cl)Cl Not approved TRPV4 Channel This inhibition of TRPV4-mediated signaling can affect downstream pathways involved in the regulation of the circadian clock.
CC(=O)N1CC2=C([C@@H]1C(=O)NC3=CC=C(C=C3)C(C(F)(F)F)(C(F)(F)F)O)C=CC(=C2)S(=O)(=O)C None ROR gamma ROR, RORγ binding
COC1=C(C=C2CC(C(=O)C2=C1)CC3=C(C=CC=N3)C(F)(F)F)N4CCOCC4 None ROR gamma ROR
CCS(=O)(=O)C1=CN=C(C=C1)CNC(=O)C2=CC3=C([C@H](N(C3)CC4CCC(CC4)C(F)(F)F)C(C)C)N=C2 Not approved ROR gamma RORyt/RORc inhibitor
CC(C)N1C=NC2=C1N=CN=C2N(CC3=CC(=CC=C3)C(F)(F)F)CC4=C(C=CC=C4)[N+](=O)[O-] None CKI delta Inhibits CKIδ
C1COCCC1N2C3=NC=NC(=C3C(=N2)COC4=CC(=CC=C4)Cl)N Not approved CK1δ CK1 Inhibition
CC1=CC2=C(C=C1Cl)N=C(S2)NC(=O)CC3=CC=CC=C 3 None CKI delta Inhibits casein kinase 1 delta (CKIδ) activity, Inhibits CKIδ
C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4 Not approved CK1δ Binds to the ATP‑binding site of CK2
COC1=CC(=C(CN(C2=C3N=CN(C3=NC=N2)C(C)C)CC2=CC(=CC=C2)C(F)(F)F)C=C1OC)[N+](=O)[O-] none CKI delta Inhibits casein kinase 1 delta (CKIδ) activity, Inhibits CKIδ